| Literature DB >> 32257583 |
Nathchar Naowarojna1, Seema Irani2, Weiyao Hu1,3, Ronghai Cheng1, Li Zhang1, Xinhao Li3, Jiesheng Chen3, Yan Jessie Zhang2, Pinghua Liu1.
Abstract
Ergothioneine is a thiohistidine derivative with potential benefits on many aging-related diseases. The central step of aerobic ergothioneine biosynthesis is the oxidative C-S bond formation reaction catalyzed by mononuclear nonheme iron sulfoxide synthases (EgtB and Egt1). Thus far, only the Mycobacterium thermoresistibile EgtB (EgtB Mth ) crystal structure is available, while the structural information for the more industrially attractive Egt1 enzyme is not. Herein, we reported the crystal structure of the ergothioneine sulfoxide synthase (EgtB Cth ) from Candidatus Chloracidobacterium thermophilum. EgtB Cth has both EgtB- and Egt1-type of activities. Guided by the structural information, we conducted Rosetta Enzyme Design calculations, and we biochemically demonstrated that EgtB Cth can be engineered more toward Egt1-type of activity. This study provides information regarding the factors governing the substrate selectivity in Egt1- and EgtB-catalysis and lays the groundwork for future sulfoxide synthase engineering toward the development of an effective ergothioneine process through a synthetic biology approach.Entities:
Keywords: Rosetta Enzyme Design; enzyme engineering; ergothioneine; nonheme iron enzyme; sulfur-containing natural product
Year: 2019 PMID: 32257583 PMCID: PMC7133768 DOI: 10.1021/acscatal.9b02054
Source DB: PubMed Journal: ACS Catal Impact factor: 13.084